Axway Software: Disclosure of Transactions in Own Shares

PARIS--(BUSINESS WIRE)-- Regulatory News:

In accordance with the authorization given by the Combined General Meeting of June 6, 2018 for the implementation of a share buyback program, Axway Software SA (Paris: AXW) (LEI:96950022O6SP7FQONJ77) declares below the purchases of its own shares (FR0011040500) from December 3, 2018 to December 7, 2018:

Details of transactions, in accordance with Article 5(2)(c) of European Regulation No 596/2014 and its delegated regulation (EU) 2016/1056, are available on Axway's website, Investors section, under Regulated Information.

Disclaimer
This document is a translation into English of the original French press release. It is not a binding document. In the event of a conflict in interpretation, reference should be made to the French version, which is the authentic text.

About Axway
Axway (Euronext: AXW.PA), as a software company, unlocks digital experiences by connecting individuals, systems, businesses and customer ecosystems with digital infrastructure solutions. AMPLIFY™, Axway’s hybrid integration platform, connects data from any device anywhere, expands collaboration, fuels millions of apps and supplies real-time analytics to build customer experience networks. From idea to execution, Axway’s expertise in API management, secure file exchange and B2B/EDI integration have solved the toughest data challenges for more than 11,000 organizations in 100 countries. To learn more, visit http://www.investors.axway.com/en or Axway IR mobile App available on Apple Store & Android.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181214005228/en/

Axway
Investor Relations:
Arthur Carli
+33 (0)1 47 17 24 65
[email protected]

Press Relations:
Sylvie Podetti
+33 (0)1 47 17 22 40
[email protected]

Source: Axway

You May Also Be Interested In

• Shell pauses $3 billion share buyback program due to ARC deal
• TRUQAP® (capivasertib) combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer
• Via Transportation, Inc. Securities Class Action Result of Undisclosed Growth Obstacles and approximately 70% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC